Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocyte's lead program is a prostate specific membrane antigen (PSMA)-targeted radioligand therapy, 177Lu-PSMA-617, entering phase 3 for metastatic castration resistant prostate cancer (mCRPC). Endocyte is also advancing its adaptor-controlled CAR T-cell therapy into the clinic, where it will be studied in osteosarcoma.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Purdue Research Park, 3000 Kent Avenue,united States
- Phone
- (765) 463-7175
- in****@****yte.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- endocyte.com
- HQ
- West Lafayette, IN
Endocyte Questions
Endocyte's helpline number is (765) 463-7175
Endocyte's website is endocyte.com
Endocyte's LinkedIn profile is https://www.linkedin.com/company/independent-consultant-for-endocyte
Endocyte has
14 employees.
View email and phone details for 14
employees at Endocyte.
Endocyte's industry is
Pharmaceutical Manufacturing
Endocyte's top competitors are
Novartis,
Baxalta,
Fergene,
Umoja Biopharma,
Regeneron,
Inotiv,
Biomarin Pharmaceutical Inc.,
Fusion Pharmaceuticals,
Chimerix, A Jazz Pharmaceuticals Company,
Advanced Accelerator Applications.
Endocyte's support email address is info@endocyte.com
Endocyte's categories are Pharmaceutical Manufacturing
Endocyte's founding year is 1996
